EKSO BIONICS HOLDINGS, INC. Quarterly Common Stock, Shares, Outstanding from Q1 2012 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Ekso Bionics Holdings, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q1 2012 to Q3 2024.
  • Ekso Bionics Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 22M shares, a 54.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 22M +7.76M +54.5% Sep 30, 2024 10-Q 2024-10-28
Q2 2024 18.4M +4.64M +33.6% Jun 30, 2024 10-Q 2024-07-29
Q1 2024 18.1M +4.75M +35.6% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 14.8M +1.65M +12.5% Dec 31, 2023 10-Q 2024-10-28
Q3 2023 14.2M +1.11M +8.44% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 13.8M +797K +6.13% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 13.3M +498K +3.88% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 13.2M +510K +4.02% Dec 31, 2022 10-K 2024-03-04
Q3 2022 13.1M +463K +3.66% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 13M +355K +2.81% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 12.8M +189K +1.49% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 12.7M +4.34M +52% Dec 31, 2021 10-K 2023-03-28
Q3 2021 12.7M +4.35M +52.3% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 12.7M +4.84M +62% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 12.7M +6.81M +117% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 8.35M +2.55M +44.1% Dec 31, 2020 10-K 2022-02-24
Q3 2020 8.32M -66.6M -88.9% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 7.81M -67.1M -89.6% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 5.84M -61.7M -91.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 5.8M -57.2M -90.8% Dec 31, 2019 10-K 2021-02-25
Q3 2019 75M +12.3M +19.7% Sep 30, 2019 10-Q 2019-10-30
Q2 2019 74.9M +74.8M +123018% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 67.5M +7.17M +11.9% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 63M +3.02M +5.04% Dec 31, 2018 10-K 2020-02-27
Q3 2018 62.6M +2.71M +4.53% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 60.8K -25.7M -99.8% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 60.4M +38.5M +176% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 59.9M +38M +174% Dec 31, 2017 10-K 2019-02-28
Q3 2017 59.9M +38.5M +180% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 25.8M +9.41M +57.4% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 21.9M +6.3M +40.4% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 21.9M +6.87M +45.7% Dec 31, 2016 10-K 2018-03-13
Q3 2016 21.4M -81M -79.1% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 16.4M -85.7M -84% Jun 30, 2016 10-Q 2016-08-03
Q1 2016 15.6M -86.4M -84.7% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 15M -86.6M -85.2% Dec 31, 2015 10-K 2017-03-15
Q3 2015 102M +23.8M +30.3% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 102M +23.6M +30.1% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 102M +23.5M +30% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 102M +80.5M +381% Dec 31, 2014 10-K 2016-03-14
Q3 2014 78.6M +72.2M +1138% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 78.5M +72.1M +1136% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 78.5M +56.5M +257% Mar 31, 2014 10-Q 2014-05-13
Q4 2013 21.1M Dec 31, 2013 10-K 2015-03-19
Q3 2013 6.35M Sep 30, 2013 10-Q/A 2013-11-18
Q2 2013 6.35M Jun 30, 2013 10-Q 2013-08-15
Q1 2013 22M +15.6M +246% Mar 31, 2013 10-Q 2014-02-19
Q1 2012 6.35M Mar 31, 2012 10-K 2013-07-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.